Cargando…

Dramatic response to albendazole in transplantation candidates with unresectable hepatic alveolar hydatid disease

Long‐term albendazole treatment should be given to all patients with unresectable hepatic alveolar echinococcosis as dramatic regression is possible in 15%–20%. It may be prudent to prepare a living donor for possible salvage transplant in case of a severe complication. Preemptive transplantation in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ocak, Sönmez, Poyanlı, Arzu, Güllüoğu, Mine, İbiş, Cem, Tekant, Yaman, Özden, İlgin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380084/
https://www.ncbi.nlm.nih.gov/pubmed/34457290
http://dx.doi.org/10.1002/ccr3.4666
_version_ 1783741125517901824
author Ocak, Sönmez
Poyanlı, Arzu
Güllüoğu, Mine
İbiş, Cem
Tekant, Yaman
Özden, İlgin
author_facet Ocak, Sönmez
Poyanlı, Arzu
Güllüoğu, Mine
İbiş, Cem
Tekant, Yaman
Özden, İlgin
author_sort Ocak, Sönmez
collection PubMed
description Long‐term albendazole treatment should be given to all patients with unresectable hepatic alveolar echinococcosis as dramatic regression is possible in 15%–20%. It may be prudent to prepare a living donor for possible salvage transplant in case of a severe complication. Preemptive transplantation in mildly symptomatic patients should be discouraged.
format Online
Article
Text
id pubmed-8380084
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83800842021-08-27 Dramatic response to albendazole in transplantation candidates with unresectable hepatic alveolar hydatid disease Ocak, Sönmez Poyanlı, Arzu Güllüoğu, Mine İbiş, Cem Tekant, Yaman Özden, İlgin Clin Case Rep Case Reports Long‐term albendazole treatment should be given to all patients with unresectable hepatic alveolar echinococcosis as dramatic regression is possible in 15%–20%. It may be prudent to prepare a living donor for possible salvage transplant in case of a severe complication. Preemptive transplantation in mildly symptomatic patients should be discouraged. John Wiley and Sons Inc. 2021-08-21 /pmc/articles/PMC8380084/ /pubmed/34457290 http://dx.doi.org/10.1002/ccr3.4666 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Ocak, Sönmez
Poyanlı, Arzu
Güllüoğu, Mine
İbiş, Cem
Tekant, Yaman
Özden, İlgin
Dramatic response to albendazole in transplantation candidates with unresectable hepatic alveolar hydatid disease
title Dramatic response to albendazole in transplantation candidates with unresectable hepatic alveolar hydatid disease
title_full Dramatic response to albendazole in transplantation candidates with unresectable hepatic alveolar hydatid disease
title_fullStr Dramatic response to albendazole in transplantation candidates with unresectable hepatic alveolar hydatid disease
title_full_unstemmed Dramatic response to albendazole in transplantation candidates with unresectable hepatic alveolar hydatid disease
title_short Dramatic response to albendazole in transplantation candidates with unresectable hepatic alveolar hydatid disease
title_sort dramatic response to albendazole in transplantation candidates with unresectable hepatic alveolar hydatid disease
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380084/
https://www.ncbi.nlm.nih.gov/pubmed/34457290
http://dx.doi.org/10.1002/ccr3.4666
work_keys_str_mv AT ocaksonmez dramaticresponsetoalbendazoleintransplantationcandidateswithunresectablehepaticalveolarhydatiddisease
AT poyanlıarzu dramaticresponsetoalbendazoleintransplantationcandidateswithunresectablehepaticalveolarhydatiddisease
AT gulluogumine dramaticresponsetoalbendazoleintransplantationcandidateswithunresectablehepaticalveolarhydatiddisease
AT ibiscem dramaticresponsetoalbendazoleintransplantationcandidateswithunresectablehepaticalveolarhydatiddisease
AT tekantyaman dramaticresponsetoalbendazoleintransplantationcandidateswithunresectablehepaticalveolarhydatiddisease
AT ozdenilgin dramaticresponsetoalbendazoleintransplantationcandidateswithunresectablehepaticalveolarhydatiddisease